Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

Summary

The aim of this study is to assess the effectiveness in preventing exacerbation of 52 weeks lysozyme administration in patients with COPD.

Timeline

Start

2012-08

Primary completion

2015-01

Completion

2015-03

Outcome

Missed primary endpoint

release “patients with COPD (Study LYS-002), a statistically significant improvement over placebo in the study's primary endpoint could not be verified.” eisai.com ↗

Drugs

Indications